QC
IOSP icon

Quantedge Capital’s Innospec IOSP Stock Holding History

Quantedge Capital’s Portfolio IOSP Stock Details IOSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,900
Closed -$358K – 198
2024
Q2 		$358K Buy
+2,900
New +$363K 0.13% 137

Other funds holding IOSP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Quantedge Capital's IOSP Position: Q3 2024 in Review

Quantedge Capital sold out of Innospec (IOSP) in Q3 2024, closing a stake of 2,900 shares — an estimated $358K sold.

Quantedge Capital first reported a position in IOSP in Q2 2024 and held it in 1 quarter. The position peaked at $358K in Q2 2024. 259 funds tracked by Wall St. Rank hold IOSP as of Q3 2024.

  • Quantedge Capital reported no remaining Innospec position as of Q3 2024 after selling out during the quarter.
  • Quantedge Capital sold 2,900 Innospec shares in Q3 2024, an estimated $358K.
  • Quantedge Capital first reported a position in Innospec in Q2 2024 and held it in 1 quarter.
  • Quantedge Capital's Innospec position peaked at $358K in Q2 2024.
  • 259 funds tracked by Wall St. Rank held Innospec as of Q3 2024.

Based on Quantedge Capital's 13F filing for Q3 2024, filed 13 Nov 2024.